CareMax, Inc.

NasdaqGS:CMAX Rapport sur les actions

Capitalisation boursière : US$7.9m

CareMax Résultats passés

Passé contrôle des critères 0/6

CareMax's earnings have been declining at an average annual rate of -96.7%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 40.6% per year.

Informations clés

-96.7%

Taux de croissance des bénéfices

-108.9%

Taux de croissance du BPA

Healthcare Croissance de l'industrie8.5%
Taux de croissance des recettes40.6%
Rendement des fonds propresn/a
Marge nette-99.8%
Dernière mise à jour des bénéfices30 Jun 2024

Mises à jour récentes des performances passées

Recent updates

US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

Aug 14
US$2.60: That's What Analysts Think CareMax, Inc. (NASDAQ:CMAX) Is Worth After Its Latest Results

CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Jun 20
CareMax, Inc.'s (NASDAQ:CMAX) Subdued P/S Might Signal An Opportunity

Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

May 13
Here's What Analysts Are Forecasting For CareMax, Inc. (NASDAQ:CMAX) After Its First-Quarter Results

Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

Mar 11
Analysts Have Just Cut Their CareMax, Inc. (NASDAQ:CMAX) Revenue Estimates By 11%

CareMax: Numbers Are Strong, Compelling Value On Offer

Sep 16

CareMax GAAP EPS of -$0.11 misses by $0.09, revenue of $172.28M beats by $36.85M

Aug 09

CareMax: Steward Health Care Acquisition Highlights Growth Ambitions

Jul 02

CareMax: Network Of Comprehensive Care Centers Serving Medicare Beneficiaries

Oct 18

Ventilation des recettes et des dépenses

Comment CareMax gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.


Historique des gains et des recettes

NasdaqGS:CMAX Recettes, dépenses et bénéfices (USD Millions )
DateRecettesLes revenusDépenses G+ADépenses de R&D
30 Jun 24785-783820
31 Mar 24810-645900
31 Dec 23751-683950
30 Sep 23764-207960
30 Jun 23719-126970
31 Mar 23667-103930
31 Dec 22631-38880
30 Sep 22585-52860
30 Jun 22532-44760
31 Mar 22405-25660
31 Dec 21296-7460
30 Sep 21206-2300
30 Jun 2112512170
31 Mar 21106650
31 Dec 20103890
30 Sep 201017140
31 Dec 19916320
31 Dec 18723250

Des revenus de qualité: CMAX is currently unprofitable.

Augmentation de la marge bénéficiaire: CMAX is currently unprofitable.


Analyse des flux de trésorerie disponibles par rapport aux bénéfices


Analyse de la croissance passée des bénéfices

Tendance des revenus: CMAX is unprofitable, and losses have increased over the past 5 years at a rate of 96.7% per year.

Accélération de la croissance: Unable to compare CMAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Bénéfices par rapport au secteur d'activité: CMAX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).


Rendement des fonds propres

ROE élevé: CMAX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Rendement des actifs


Rendement des capitaux employés


Découvrir des entreprises performantes dans le passé